PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

CSafe Global Continues Expansion Across Asia with Two New Hub Locations in China

Through a partnership with C.H. Robinson, CSafe will establish hub operations in Beijing and Guangzhou to support local customers.

CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, continues to expand operations across Asia opening two new hub operations in Beijing and Guangzhou, China.

The Beijing (PEK) facility will provide 500 sqm (5382 sq. ft.) of warehouse space to clean and store CSafe RKN and RAP containers. CSafe will have 400 sqm (4305 sq. ft.) in the Guangzhou (CAN) facility. This strategic partnership with C.H. Robinson provides CSafe access to their extensive network and logistics experience. C.H. Robinson’s vast network of locations across China – including 19 of the major cities – gives CSafe the flexibility to easily expand and provide containers to customers in key locations quickly.

These two new facilities bring CSafe’s total station count to 11 across the APAC region with more to come in 2021. “Adding these to our established operations in Shanghai and Hong Kong, we are able to easily supply CSafe containers anywhere in mainland China,” said Tom Weir, CSafe Global COO. “Our team is also working on agreements in several other locations across the region to establish additional hubs and comprehensive service centers for container maintenance and repairs this year in other major cities in China. We are very strategic about where we establish hubs and service centers to ensure we invest wisely and always optimize operations and service for our customers,” he continued.

CSafe continues to deliver on its mission to the highest quality temperature-controlled containers in the industry to ensure pharmaceuticals and biologics are delivered to patients in optimal condition for maximum efficacy. By investing in best-in-class facilities in strategic locations worldwide, CSafe can provide top tier service to customers in their local area.  

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026